BID Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of BID Antibodies for research in apoptosis and cell signaling. BID monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BID, a pro-apoptotic member of the Bcl-2 family, plays a crucial role in the intrinsic pathway of apoptosis by promoting mitochondrial outer membrane permeabilization. BID's function is vital in regulating cell death and survival, making it an essential target for studies related to cancer, neurodegenerative diseases, and other conditions where apoptosis is dysregulated. Understanding BID's molecular mechanisms can provide insights into therapeutic strategies aimed at modulating cell death. Researchers worldwide rely on BID monoclonal antibodies to advance their understanding of cellular pathways and disease mechanisms. BID monoclonal antibodies enable detailed investigation of protein interactions and signaling cascades in various biological systems. Santa Cruz Biotechnology monoclonal antibodies for BID continue to support breakthrough discoveries in cell death research and therapeutic development.